Peer Review History
| Original SubmissionJune 16, 2022 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-22-17318Emotional responses to COVID-19 stressors affect broader health decision-makingPLOS ONE Dear Dr. Gustafson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 06 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Christoph Strumann Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. Additional Editor Comments: The manuscript has been evaluated by two reviewers. Both highlighted in their comments that the article needs a revision before it could be accepted for publication. While Reviewer 2 requests a major revision to significantly reduce the length of the manuscript, Reviewer 1’s major concern is the use of the term "causality". Since all individuals have been exposed by the pandemic outbreak, a control group is missing invalidating the use of a natural experiment. The authors should make the related assumptions more explicit, why it is still possible to base the analysis on a natural experiment. Please state explicitly why you are convinced that your findings can be interpreted in a causal manner. The DAG (=directed acyclic graph) figure suggested by Reviewer#1 could be helpful here. Otherwise, Reviewer 1 suggests to avoid any language of causality. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript presents two surveys (custom and a national survey) in which respondents who experienced higher stress in the form of income loss and local case counts felt more hopelessness, and hopelessness was associated with avoiding health information and delaying healthcare. The manuscript is generally well-written, though some sections repeat what was previously presented. The N is large and being a representative sample makes the finding stronger. I liked the manuscript; I think it adds to the literature. The only major concern is the language of causality in a non-experimental design, but this can be easily remedied. Some comments: The title needs to be more specific, addressing avoidance of health information and healthcare utilization. Under abstract: Substitute the word "lead" to a non-causal word. Mental health is more than hopelessness, so indeed be specific and drop 'mental health'. The fact that there are 2 separate studies is not well-conveyed in the abstract. State explicitly that there are 2 separate studies. Under introduction. The statement "Information shapes beliefs and affects private behavior" needs to be supported by other references than #36 and 37, which do not examine this statement. The authors should explain why they examined accessing treatment for non-COVID health problems as one of the DVs, an already-documented issue. Were they trying to replicate findings? To show the same findings using a big sample? To examine the process/mediators? Please present the rationale. Structure of writing: LL 162-189 report results, and this is the introduction. The results have no place in the introduction section. Remove words of causation or prediction from the manuscript. As most measures were taken at same or equivalent times, the word 'predicted'/'predictor' or 'increase' or 'effect' should be replaced with words of association (l. 164, 262, and elsewhere). Please provide a DAG (=directed acyclic graph) figure conceptualizing the relationship between all variables in the study. Under methods. Structure each survey under respondents, materials, procedure, design. The writing is not structured enough. Explain why a four-category variable of hopelessness made into a 2-category variable. Streamline the analysis section. The rationale is repeated here after being presented above. There is no need for this. On l. 312 and 341 remove the word "impacts". No experiment was performed. This is a cross sectional survey and variables have no impact on each other. 2.2.1 – it seems to me the analyses are only on the ARM study, so it's unclear why the title refers also to HPS21. HPS21 is explained under 2.2.2. The national survey appears first under 2.2.1 on l. 333 as an outcome, but this is unclear how it can be an outcome in the costumed survey. Under Results. The descriptive data is very interesting, especially the variance between surveys. Pls substitute 'effect' with association in l. 472. Also impact in l. 488 and 496. The same re 'impact' all over the results. The authors engage in a lot of interpretation in the results section, and may consider reserving it for the discussion (for example, ll. 503-508). Table 8 is not very clear in terms of what happens with each stressor; it seems both independent variables were lumped together. A graphic representation could be helpful. In Table 10, the difference between model I and II, and model III and IV is not clear; one surmises it's the inclusion of demographic variables, but it should be explicitly stated. Under discussion. Compare the variables of foregoing medical care to international data, preferably to high resource countries where medical care is less a matter of out-of-pocket payments than in the US. Delayed care was documented in many countries, but the levels may vary. There is such data, and it may increase the claim that the emotional response may drive the decision and behavior and not income issues. Reviewer #2: Thank you for this thoughtful and relevant article. I appreciate the authors' willingness to step out of their comfort zones of their historically published work and incorporate the relevance of the COVID-19 pandemic with health-related decision making. The authors wove into this work the relevance of AMR and the impact on public health. This paper is excellently written in outstanding English with appropriate grammar and sentence structure. I am requesting a major revision as it needs significant reduction in length to make this a digestible and relevant read for the reader. In summary Introduction: I would suggest greatly reducing the introduction to 2 pages, to make a very concise and compelling draw for the reader to fully read this work. Please consider utilizing the paragraph starting in line 80 and ending in line 85 ("In this study, we examine a novel question: can one crisis—the COVID-19 pandemic—change decision-making in unrelated but critical personal and societal health issues by affecting general feelings of hopelessness? We use a natural experiment—variation in exposure to COVID-19-related stressors (income loss and local COVID-19 cases)—to examine the impact of a large-scale crisis on decisions to forego or delay necessary medical care and to avoid information about AMR.") to be the final paragraph of the introduction. It is an excellent description of the study. Any relevant information you would like to include, I would suggest placing before this paragraph. Please avoid the study description in the introduction itself. It creates some confusion and description/methods should be kept entirely to the methods section. Lines 102 through 189 should be greatly condensed to the methods section or omitted if possible. Methods: Please attempt to condense the methods as well to 2-3 pages and avoid too much explanation, such as line 206, as the methods should be straight forward and to the point so the reader is not bogged down in the reading prior to reviewing the results section. Results: Well-written and contains a wealth of data. It may be beneficial to move some of the data to Supplemental tables as 10 Tables is on the heavy end for a manuscript. The suggestion here is to limit your results to 5 tables and speak to the other data either in writing or by presenting as Supplemental material. Please avoid sentences like 374-376 which are better suited for the discussion (and a similar sentence was found in the discussion). Discussion: This is concise and well-presented. I appreciate the understanding of limitations on the study. Conclusion: This was not provided - kindly write a brief 1 paragraph conclusion of the findings and relevance to future work. Thank you ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-22-17318R1Emotional responses to COVID-19 stressors increase avoidance of health information and access to carePLOS ONE Dear Dr. Gustafson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Two reviewers have evaluated the revision of the manuscript. Unfortunately, one of the previous reviewers was unable to review. After a very time-consuming search for a new reviewer, I am now able to make a decision on your manuscript, i.e. the article needs to be revised before it can be accepted for publication. I agree with Reviewer #3 that it would be a cleaner contribution to the literature if the authors focus the manuscript on how one existential threat (COVID) can reduce information seeking about another existential threat (AMR). This would allow you to rewrite the manuscript to be about information avoidance rather than switching between decision-making, avoidance behavior, or information avoidance. It would also give you the space to properly report the mediation analysis, which has not received sufficient attention in the methods or results. In addition, a stronger focus would help to increase the clarity of the study. Please submit your revised manuscript by May 04 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Christoph Strumann Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Dear Author - Thank you so much for the extensive revisions to the manuscript. Your attention to detail in updated is noted and appreciated. Reviewer #3: I think that the framing of the manuscript as a study of decision-making is too broad. My recommendation would be to narrow the scope to information avoidance and remove the mention of decision making and situating the study in the larger field of decision making (impact of affect on decision-making or financial scarcity and decision making etc…). I don't think we can say with any confidence that the effects described in these other decision making studies apply to information avoidance. The same goes for describing the outcome as health behavior (abstract) which will likely confuse the reader. Not seeking healthcare is a broader and more multiply determined phenomenon than a single information avoidance decision about viewing a video about AMR. I think that lumping them together does a disservice to both. My preference would be to see the two studies split apart into two separate papers and the intro and discussions reworked to focus on the different outcome variables. That said, several of my comments assume that this will not be the case. The most relevant literature reviews seem underdeveloped. I expected to read a more extensive summary of (1) studies that demonstrated an increase in hopelessness and other depressive symptoms during COVID, (2) determinants of information avoidance and, (3) the impact of COVID on health care seeking and justifying why we can consider this information avoidance or even avoidant behavior. The later is a real sticking point for me. We don’t have information on why people didn’t have care. Perhaps there was no care to receive. That was an issue for many during the pandemic. I appreciate that hopelessness predicted not receiving care so it seems like the pathway is similar to the AMR study, but I didn’t find enough information about the mediation model to feel reassured that there was true causal mediation taking place. I realize that a previous reviewer requested a shorter methods section and all the measures descriptions have been removed. This seems unusual but I defer to the editor. If they are added back in they could be rewritten to be clearer. I would give each construct its own mini paragraph and describe question wording and response options. You might consider switching the order of paragraphs 1 and 2 on page 7 so you introduce the study design first and follow that with what people did in the survey. One thing that might help with clarity would be to describe what the participants did in the studies rather than the survey doing things to people. I don't think the analysis section indicates weighting/approach to using complex survey data unless that's in supplemental materials. Lines 166-167 in the methods describe 4 nested models. I believe various covariates were added to the model. Please clarify this section so that the reader understand which variables were included in which models and why. These methods don't need to be reiterated in the results but I think a summary of the results and any important differences between the models could be articulated more clearly. It’s unusual for the results to be written in present rather than past tense. While some descriptive stats for the two samples makes sense, I didn’t understand the logic of presenting these as a comparison, especially since they aren’t compared in any inferential way. The stats are presented in various ways in the narrative OR and 95% CI, just the OR or just an approximation of the odd (e.g., 1.5 times). Could this be standardized so that the OR, 95% CI and p-value are always presented? Could asterisks indicating p-values be added to the tables? In the interest of preciseness the results only need to be reported once. For example in the following the first sentence can be dropped although the stats for COVID cases seem to be missing so that should be added. I’d do a careful edit for redundancy. " In the analysis of HPS21 data, experienced loss of income, expected loss of income, and state-level COVID-19 cases increase the odds of experiencing hopelessness. Experienced income loss (aOR: 2.42, 95% CI: 2.35, 3.50) and expected income loss (aOR: 2.75, 95% CI: 2.49, 3.04) significantly increase the likelihood that individuals experience higher levels of hopelessness.” Lines 255-260 seem to editorialize on the results and would seem better apportioned into parts that belong in the methods and the limitations. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Emotional responses to COVID-19 stressors increase information avoidance about an important unrelated health threat PONE-D-22-17318R2 Dear Dr. Gustafson, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Christoph Strumann Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-17318R2 Emotional responses to COVID-19 stressors increase information avoidance about an important unrelated health threat Dear Dr. Gustafson: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Christoph Strumann Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .